Company Filing History:
Years Active: 2013
Title: The Innovative Contributions of Pamela Braemer
Introduction
Pamela Braemer is a notable inventor based in Weinheim, Germany. She has made significant contributions to the field of biotechnology, particularly in the development of anti-P-selectin antibodies. With a total of 2 patents, her work has the potential to greatly benefit patients suffering from critical limb ischemia and peripheral arterial occlusive disease.
Latest Patents
Braemer's latest patents include innovative methods for inhibiting the binding of P-selectin to PSGL-1 using anti-P-selectin antibodies. This invention focuses on antibodies that contain an Fc part derived from human origin and do not bind complement factor C1q. These antibodies exhibit new and inventive properties that can provide substantial benefits for patients with critical limb ischemia or peripheral arterial occlusive disease. Additionally, she has developed nucleic acid molecules encoding these anti-P-selectin antibodies, further enhancing the therapeutic potential of her inventions.
Career Highlights
Throughout her career, Pamela Braemer has worked with prominent companies in the pharmaceutical industry, including Hoffmann-La Roche Inc. and F. Hoffmann-La Roche AG. Her experience in these organizations has allowed her to refine her expertise and contribute to groundbreaking research in her field.
Collaborations
Braemer has collaborated with esteemed colleagues such as Yvo Graus and Jacques Himber, further enriching her work and expanding the impact of her inventions.
Conclusion
Pamela Braemer's innovative work in the development of anti-P-selectin antibodies showcases her dedication to advancing medical science. Her contributions have the potential to improve the lives of many patients facing serious health challenges.